Hereditary papillary renal carcinoma (HRPC) is associated with activating mutations in the MET gene on chromosome 7 [41]; this oncogene encodes a membrane tyrosine kinase receptor whose ligand is hepatocyte growth factor (HGF). This evidence concerns the gene HGF and hereditary papillary renal cell carcinoma.